Guardant Health
GH
#1530
Rank
A$20.37 B
Marketcap
A$156.89
Share price
2.11%
Change (1 day)
176.08%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Guardant Health (GH) - Total assets

Total assets on the balance sheet as of September 2025 : A$1.92 Billion

According to Guardant Health 's latest financial reports the company's total assets are A$1.92 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Guardant Health - Total assets on balance sheet (from 2017 to 2025)

Total assets by year

Year Total assets Change
2024-12-31A$2.38 B-8.91%
2023-12-31A$2.62 B10.83%
2022-12-31A$2.36 B-22.19%
2021-12-31A$3.04 B2.92%
2020-12-31A$2.95 B114.91%
2019-12-31A$1.37 B64.88%
2018-12-31A$0.83 B89.82%
2017-12-31A$0.43 B171.64%
2016-12-31A$0.16 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Natera
NTRA
A$2.74 B 42.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Neogen
NEOG
A$5.08 B 164.58%๐Ÿ‡บ๐Ÿ‡ธ USA